Trump's 100% Tariffs on Pharmaceuticals Raise Concerns Over Healthcare Costs

President Trump's announcement of a 100% tariff on certain brand-name drugs has sparked concerns about rising healthcare costs and access to essential medicines. This decision could lead to increased prices for consumers and strain the healthcare system, affecting millions of Americans. While drugmakers' shares have seen a modest decline, exemptions for companies investing in the U.S. may alter market dynamics, making this a critical issue for the healthcare landscape.